Page 32 - Sanket Koul

Drug regulator CDSCO flags 3 drugs as spurious, 56 not of standard quality

CDSCO made the revelation in its monthly update for October; drugs include those used to treat acid reflux, lower cholesterol and reduce risk of heart disease

CII body calls for expansion of PLI for medical devices to more products

CII's medtech group to ask govt for strict policy on import of refurbished devices, incentives in R&D, and enhanced rebate on export duties

Expanded PMJAY for 70+ meets only 3% of target in 1st month since roll out

Although the government has not provided any timeframe to reach the 60 million target, the pace seems to have become a cause of concern in a country which is greying rapidly

Abbott launches 14-valent pneumococcal vaccine in India for children

Pneumococcal vaccines address infections caused by pneumococcal bacteria, including pneumonia, meningitis, and blood infections, collectively known as invasive pneumococcal disease

Dharmendra Pradhan launches Bharti Airtel Foundation's 'TheTeacherApp'

Platform includes 'free for life', CBSE-based resources to help educators meet evolving needs of education

Orchid Pharma to collaborate with hospital body CAHO to counter AMR

The collaboration aims to tackle AMR in India by focusing on tier 2 and tier 3 cities, bridging the gap between awareness and action, and ensuring sustainable AMR interventions

UCL inks trilateral pact with AIIMS, IIT-D to scale up medtech innovation

Collaboration comes days after UCL signed agreement with IISc Bengaluru on clinical education

Small and medium hospitals market likely to reach Rs 5 trn by FY27: Report

Report suggests the sector still faces sustainability issues due to profit crunch, expanding competition from large chains

Air pollution woes: Delhi hospitals see 50% jump in OPD visits, admissions

Jump in numbers comes as north Indian cities record AQI in excess of 350, Mumbai crosses 120

India among our top three focus markets globally, says Pearson executive

The company is seeing a huge growth opportunity in English language learning, assessment and testing, and higher education

Glenmark Pharma Q2 profit rises on strong India business performance

The company also reported a 14.6 per cent rise in revenues in the European market to Rs 687.4 crore, while recording a 1.2 per cent revenue drop in the North America market

Centre launches PAIR programme to enhance research in higher education

Each PAIR network will consist of one hub and up to seven spoke institutions

Medanta Hospitals Q2 results: Net profit rises 4.5% to Rs 130 crore

The company's ARPOB per day rose to Rs 62,140 in Q2 FY25, a marginal growth of 1.9 per cent Y-o-Y compared to Rs 61,003 reported for the same period last year

India's import dependence on key pharma ingredients may reduce by half

Two newly inaugurated units will manufacture important molecules used in several common antibiotics

Zydus Lifesciences net profit up 14% on strong India, US formulations biz

The growth is attributed to strong performances across domestic and international formulations, and double-digit growth in the consumer wellness business

Indian pharmaceutical market registers over 6% growth in October 2024

The value growth comes at a time when the IPM has registered a negative volume growth of 1.8 per cent

Govt launches Rs 500 crore scheme to strengthen medical devices industry

This initial outlay of Rs 500 crore will be for three years, up to financial year 2026-27 (FY27), according to a government communication

Fortis Healthcare Q2 profit up 5%, revenue rises 12% on strong hospital biz

The company's revenue from operations rose to Rs 1,988 crore in Q2 FY25, a 12.3 per cent Y-o-Y increase from Rs 1,770 crore reported in Q2 FY24

Yatharth Hospitals Q2FY25 results: Net profit up 12%, revenue rises 27%

The growth is attributed to higher occupancy rates and an increase in revenue per bed during the September quarter

New launches likely to fuel domestic growth: JB Pharma CEO Nikhil Chopra

JB Pharma is on track to deliver strong results in the second half of financial year 2024-25